TMPRSS2 and COVID-19: Using the TN-cyclonTM, we succeeded in demonstrating that the soluble portion of ACE2, which was removed from 17β-estradiol-treated VeroE6/TMPRSS2 cells, bound to the spike proteins of SARS-CoV-2, thereby reducing COVID-19 infectivity.